Less than half of families rate general safety policies essential to camp decisions, with 1 in 10 rating COVID precautions as a critical factor.

Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.

Research shows what key factors affect flourishing after the injury.

Bradley Zebrack reflects on the insights he’s applied from his cancer journey to his job.

Two recent University of Michigan studies published in Nature Communications reveal key findings crucial to understanding X-inactivation and X-linked gene expression in embryonic stem cells, and further implications for stem cell therapies.

Reaching the tallest peaks has not just made the veteran physician a better surgeon, it’s made him a better person.

The pandemic took a toll on older adults, but especially on those whose physical or mental health was already suffering, a new poll shows. This group may need extra support to age as well as possible.

A life-threatening stroke, followed by quick medical attention, led to Jack Jenkins’ remarkable recovery.

Hospices often prescribe medicines like Xanax, Haldol and Seroquel to patients to ease end-of-life symptoms, but a new study shows very wide variation in the chances patients will get these drugs.

A hand surgeon explains the importance of parents advocating for their child with hands that don’t look or function the same as others.

Eighty percent of patients with a subset of lymphoma saw their cancers shrink after taking zanubrutinib in a clinical trial.

Ultrasound technology has been repurposed as a technique to treat liver tumors in rats.

Sexual health is linked closely to physical and mental health for older women, with menopause playing a big role, a new poll finds.

During the lengthy hospital stays that Ann Laho’s daughter endured, one nurse’s compassion inspired the mother-daughter pair to pursue the profession and help patients the same way she helped their family.

Tina Reuben was the first patient in one of the few clinical trials for adrenal cancer and hopes that her involvement can help other patients with the rare disease live longer.